S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61

Signify Health Stock Forecast, Price & News

-0.49 (-3.21%)
(As of 12/8/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.27 million shs
Average Volume
935,383 shs
Market Capitalization
$2.52 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive SGFY News and Ratings via Email

Sign-up to receive the latest news and ratings for Signify Health and its competitors with MarketBeat's FREE daily newsletter.

Signify Health logo

About Signify Health

Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates in two segments, Home & Community Services and Episodes of Care Services. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers primarily under the Medicare Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. Its customers include health plans, governments, employers, health systems, and physician groups. The company was founded in 2017 and is headquartered in Dallas, Texas with additional offices in Austin, New York, Norwalk, and Rapid City.


See More Headlines

Industry, Sector and Symbol

Home health care services
Year Founded

Sales & Book Value

Annual Sales
$610.60 million
Book Value
$8.56 per share


Net Income
$-14.50 million
Pretax Margin




Free Float
Market Cap
$2.52 billion
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

1.93 out of 5 stars

Medical Sector

706th out of 1,394 stocks

Home Health Care Services Industry

8th out of 9 stocks

Analyst Opinion: 3.3Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Signify Health (NYSE:SGFY) Frequently Asked Questions

Is Signify Health a buy right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Signify Health in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Signify Health stock.
View analyst ratings for Signify Health
or view top-rated stocks.

When is Signify Health's next earnings date?

Signify Health is scheduled to release its next quarterly earnings announcement on Tuesday, February 8th 2022.
View our earnings forecast for Signify Health

How were Signify Health's earnings last quarter?

Signify Health, Inc. (NYSE:SGFY) issued its quarterly earnings data on Tuesday, November, 9th. The company reported $0.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.09. The firm earned $199.20 million during the quarter, compared to analysts' expectations of $185.04 million. Signify Health had a negative net margin of 2.23% and a positive trailing twelve-month return on equity of 5.78%.
View Signify Health's earnings history

What guidance has Signify Health issued on next quarter's earnings?

Signify Health updated its FY 2021 earnings guidance on Tuesday, December, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $755 million-$770 million, compared to the consensus revenue estimate of $758.83 million.

What price target have analysts set for SGFY?

10 brokerages have issued 1-year target prices for Signify Health's shares. Their forecasts range from $24.00 to $36.00. On average, they expect Signify Health's stock price to reach $31.22 in the next twelve months. This suggests a possible upside of 111.5% from the stock's current price.
View analysts' price targets for Signify Health
or view top-rated stocks among Wall Street analysts.

Who are Signify Health's key executives?

Signify Health's management team includes the following people:
  • Mr. Kyle Armbrester, CEO & Director (Age 35, Pay $1.82M)
  • Mr. Steven Senneff, Pres, Chief Financial & Admin. Officer (Age 52, Pay $1.31M)
  • Mr. David Pierre, Chief Operating Officer (Age 41)
  • Mr. Laurence Michael Orton, Chief Accounting Officer (Age 49)
  • Mr. Josh Builder, Chief Technology Officer (Age 40)
  • Ms. Jennifer Wilson DiBerardino, Head of Investor Relations & Treasurer
  • Mr. Adam Francis McAnaney, Gen. Counsel & Sec. (Age 43)
  • Ms. Kathleen Tourjee, Chief HR Officer
  • Ms. Laurel Douty, Exec. VP of Clinical Operations & Episodes of Care Services (Age 52)
  • Mr. Peter Boumenot, Chief Product Officer of Home & Community Services (Age 42)

When did Signify Health IPO?

(SGFY) raised $423 million in an IPO on Thursday, February 11th 2021. The company issued 23,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Barclays, Deutsche Bank Securities, BofA Securities, UBS Investment Bank, Baird, Piper Sandler and William Blair acted as the underwriters for the IPO.

What is Signify Health's stock symbol?

Signify Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "SGFY."

Who are Signify Health's major shareholders?

Signify Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (2.93%), Nikko Asset Management Americas Inc. (2.93%), Frontier Capital Management Co. LLC (1.37%), BlackRock Inc. (1.23%), Grosvenor Holdings L.L.C. (1.15%) and Morgan Stanley (0.61%). Company insiders that own Signify Health stock include Bradford Kyle Armbrester, David Pierre, Laurence Michael Orton, Marc D Rothman and Steve Senneff.
View institutional ownership trends for Signify Health

Which institutional investors are selling Signify Health stock?

SGFY stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Invesco Ltd., Royal Bank of Canada, First Republic Investment Management Inc., and UBS Group AG.
View insider buying and selling activity for Signify Health
or view top insider-selling stocks.

Which institutional investors are buying Signify Health stock?

SGFY stock was bought by a variety of institutional investors in the last quarter, including Nikko Asset Management Americas Inc., Sumitomo Mitsui Trust Holdings Inc., Grosvenor Holdings L.L.C., BlackRock Inc., Cerity Partners LLC, Voloridge Investment Management LLC, Cubist Systematic Strategies LLC, and George Kaiser Family Foundation. Company insiders that have bought Signify Health stock in the last two years include Bradford Kyle Armbrester, David Pierre, Laurence Michael Orton, Marc D Rothman, and Steve Senneff.
View insider buying and selling activity for Signify Health
or or view top insider-buying stocks.

How do I buy shares of Signify Health?

Shares of SGFY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Signify Health's stock price today?

One share of SGFY stock can currently be purchased for approximately $14.76.

How much money does Signify Health make?

Signify Health has a market capitalization of $2.52 billion and generates $610.60 million in revenue each year.

How many employees does Signify Health have?

Signify Health employs 2,200 workers across the globe.

What is Signify Health's official website?

The official website for Signify Health is www.signifyhealth.com.

Where are Signify Health's headquarters?

Signify Health is headquartered at 800 CONNECTICUT AVENUE, NORWALK CT, 06854.

How can I contact Signify Health?

Signify Health's mailing address is 800 CONNECTICUT AVENUE, NORWALK CT, 06854. The company can be reached via phone at 203-541-4600 or via email at [email protected].

This page was last updated on 12/9/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.